Ahmed Tawakol is Co-Director of the Cardiac MR PET CT Program and Acting Director of Nuclear Cardiology at the Massachusetts General Hospital (MGH), and Associate Professor of Medicine at Harvard Medical School. He obtained his medical degree from Stanford Medical School, then trained at Harvard’s Brigham and Women’s Hospital and MGH for Internal Medicine, Cardiology, and Nuclear Cardiology.
Dr. Tawakol is a pioneer in PET/CT imaging of atherosclerotic plaques. His group developed and validated molecular imaging as a tool to assess atherosclerotic plaque inflammation in humans. Using the technique, he’s led over a dozen multi-center PET/CT (or PET/MR) imaging trials to evaluate novel cardiovascular disease treatment strategies. Additionally, his work leverages cutting-edge multi-system imaging to elucidate mechanisms that incite cardiovascular disease (CVD). Using this approach, his group recently provided the first in-human observation linking brain activity (within the amygdala, the area of the brain determining stress) to subsequent CVD events, thus providing mechanistic insights into how psychosocial stress may predispose to CVD. He is principal investigator on multiple studies funded by the NIH, industrial sponsors, and foundations. Dr. Tawakol is also a devoted teacher and mentor, both on the wards and in the laboratory.